Also trades as: ITRMF (OTC) · $vol 0M
ITRM NASDAQ
Iterum Therapeutics plc
1W: -6.4%
1M: -79.9%
3M: -89.3%
YTD: -89.3%
1Y: -97.2%
3Y: -96.5%
5Y: -99.8%
$0.03
Last traded 2026-04-06 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-27M
Net Income
+11.8% YoY
$-20M
Free Cash Flow
+43.6% YoY
94.9%
Gross Margin
-1892.8%
Op. Margin
-2302.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE285.5%
ROA-111.3%
ROIC-104.4%
Valuation
P/E-0.1
P/B-0.2
EV/EBITDA-2.3
Leverage
Debt/Equity-4.57
Current Ratio2.13
Interest Cov.-10.6x
Quality Scores
Piotroski F5/9
Altman Z-23.55
Beneish M0.00